Tags : Finland

Mobidiag Receives Emergency Use Authorization for its Automated COVID-19 Test

Tuba Khan April 23, 2020

Shots: Shots: The company receives EUA for its Novodiag COVID-19 molecular diagnostic test used to detect SARS-CoV-2 virus rapidly and is now available in Finland and under process for obtaining […]readmore

Biosimilars Biotech

Amgen Collaborates with Orion for Commercialization of Amgevita (adalimumab, biosimilar)

Vartika Singh October 25, 2018

Shots: Amgevita is indicated to treat chronic inflammatory diseases such as moderate-to-severe RA, IBD and psoriasis Amgen Biosimilar Amgevita, is a novel adalimumab’s biosimilar to be marketed in Finland. On […]readmore

Tags : Finland

Mobidiag Receives Emergency Use Authorization for its Automated COVID-19 Test

Amgen Collaborates with Orion for Commercialization of Amgevita (adalimumab, biosimilar)

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Finland

Mobidiag Receives Emergency Use Authorization for its Automated COVID-19 Test

Amgen Collaborates with Orion for Commercialization of Amgevita (adalimumab, biosimilar)

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company